Benzinga | Mar 18, 2021 07:02AM EDT

Redhill Biopharma Q4 Sales $21.50M Miss $26.03M Estimate

Redhill Biopharma (NASDAQ:RDHL) reported quarterly sales of $21.50 million which missed the analyst consensus estimate of $26.03 million by 17.40 percent. This is a 1.25K percent increase over sales of $1.59 million the same period last year.